SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

9 Apr 2015 07:00

RNS Number : 6595J
Victrex PLC
09 April 2015
 



 

 

 

 

 

9 April 2015

Victrex plc

Half year and pre-close trading update

'A good first half; well positioned for full year progress'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its half year and pre-close trading update for the six months ended 31 March 2015.

Overall, Victrex delivered a good first half performance. Group revenue of £130.3m was 9% ahead of the prior year (H1 2014: £119.9m), with Group sales volume of 2,028 tonnes 28% ahead of the prior year (H1 2014: 1,584 tonnes). The first half performance reflects a continuing positive contribution from Consumer Electronics and slightly lower sales in our Invibio medical business. Group gross margins saw improvement compared to the first half of 2014, reflecting better manufacturing efficiencies.

In Victrex Polymer Solutions (VPS), lower sales into oil and gas were offset by growth in our other markets. Commissioning of the first production stream on our third PEEK manufacturing plant is now complete and successfully started up on schedule. In Invibio, performance reflected the impact from industry consolidation in the US during Q1, as previously communicated, although we saw an improvement in Q2. Invibio revenue of £25.9m was 4% down on the prior year (H1 2014: £26.9m) and flat in constant currency, although our focus remains on continued improvement as we enter the second half.

The adverse currency impact seen by the Group during the first half will also continue into the second half. However, as previously communicated, we continue to expect that we will fully overcome the currency impact for the full year.

David Hummel, Chief Executive of Victrex, said: "Victrex delivered a good first half performance overall. Although we are mindful of the tougher comparatives for the second half and the continued caution in the oil and gas market, we remain well positioned for progress over the full year."

Victrex will report its interim results on Tuesday 19 May 2015.

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGUCPCUPAGAR
Date   Source Headline
4th Jan 20121:38 pmRNSAnnual Information Update
4th Jan 201211:35 amRNSAnnual Financial Report
3rd Jan 201211:23 amRNSHolding(s) in Company
30th Dec 201112:00 pmRNSTotal Voting Rights
19th Dec 201112:00 pmRNSDirector/PDMR Shareholding
13th Dec 20113:43 pmRNSDirector/PDMR Shareholding
6th Dec 20117:00 amRNSFinal Results
1st Dec 201111:24 amRNSBlocklisting Interim Review
30th Nov 201111:48 amRNSTotal Voting Rights
17th Nov 201111:43 amRNSDirector/PDMR Shareholding
2nd Nov 20114:22 pmRNSHolding(s) in Company
31st Oct 20111:52 pmRNSTotal Voting Rights
19th Oct 20111:45 pmRNSDirector/PDMR Shareholding
6th Oct 20113:27 pmRNSHolding(s) in Company
6th Oct 20117:02 amRNSDirectorate Change
6th Oct 20117:00 amRNSYear End Trading Update
30th Sep 20112:14 pmRNSTotal Voting Rights
19th Sep 20114:22 pmRNSDirector/PDMR Shareholding
6th Sep 20112:52 pmRNSHolding(s) in Company
31st Aug 20113:38 pmRNSTotal Voting Rights
17th Aug 20113:26 pmRNSDirector/PDMR Shareholding
10th Aug 201110:48 amRNSHolding(s) in Company
4th Aug 20117:00 amRNSInterim Management Statement
29th Jul 20113:52 pmRNSTotal Voting Rights
29th Jul 20112:05 pmRNSHolding(s) in Company
19th Jul 20113:59 pmRNSHolding(s) in Company
19th Jul 20111:40 pmRNSDirector/PDMR Shareholding
4th Jul 20114:09 pmRNSHolding(s) in Company
1st Jul 20111:23 pmRNSTotal Voting Rights Replacement
30th Jun 20113:38 pmRNSDirector/PDMR Shareholding
27th Jun 20111:47 pmRNSHolding(s) in Company
17th Jun 20112:21 pmRNSDirector/PDMR Shareholding
8th Jun 20113:55 pmRNSDirector/PDMR Shareholding
1st Jun 201111:07 amRNSBlocklisting Interim Review
1st Jun 201111:01 amRNSTotal Voting Rights
24th May 20117:00 amRNSHalf Yearly Report
18th May 20112:20 pmRNSDirector/PDMR Shareholding
6th May 20112:53 pmRNSHolding(s) in Company
5th May 20114:22 pmRNSHolding(s) in Company
4th May 20113:00 pmRNSTotal Voting Rights
4th May 20112:51 pmRNSHolding(s) in Company
19th Apr 20112:44 pmRNSDirector/PDMR Shareholding
7th Apr 20117:00 amRNSTrading Update
1st Apr 201111:00 amRNSTotal Voting Rights
25th Mar 20111:59 pmRNSDirector Declaration
17th Mar 20112:44 pmRNSDirector/PDMR Shareholding
14th Mar 201112:30 pmRNSHolding(s) in Company
2nd Mar 201110:53 amRNSTotal Voting Rights
17th Feb 20112:36 pmRNSDirector/PDMR Shareholding
9th Feb 201110:21 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.